Quality improvement
Interventional Oncology
IRs provide patients with primary and secondary liver cancer with high-quality, high-impact care in a more cost-efficient way than other specialties, according to a study published online in the Journal of Vascular and Interventional Radiology (JVIR) on Oct. 12.
The study, funded by SIR, reviewed Medicare data from 2016–2021 covering approximately 110,000 patients per year. The authors found that IRs treated nearly 51% of Medicare patients with liver cancer, with the volume increasing over time as routine oncologic care increasingly relies on IR. The researchers also found IR to be more cost-efficient than other specialties involved in liver cancer care.
Thank you to the paper’s authors Nishita Kothary, MD, FSIR, C. Matthew Hawkins, MD, MBA, FSIR, Ashley Maleki, CPC, CPMA, Wafa Q. Khan, MHA, and Danny R. Hughes, PhD.
More news from SIR
-
Guidewire
![]()
Updated guidelines for adult cancer pain
![]()
NCCN has incorporated an SIR recommendation into its 2026 Adult Cancer Pain Guidelines. View the updated guideline.
-
Guidewire
![]()
VIRTEX measure supports consistent assessment of liver cancer treatment response
![]()
VIRTEX helps IR practices consistently assess liver cancer treatment response and use outcomes data to support quality improvement.
Quality improvement
Practice development
VIRTEX
Clinical data registries
-
Guidewire
![]()
New paper outlines growing role of IR in liver cancer treatment
![]()
Read more on how IRs are playing a growing, cost-efficient role in liver cancer care, according to new JVIR research.
IR research
JVIR
-
Guidewire
![]()
Is your practice visible to the patients and referring providers you want to reach?
![]()
Looking to grow your IR practice? Find healthcare marketing, branding and digital outreach experts in the SIR Vendor Directory to help expand awareness and strengthen referral networks.
-
Guidewire
![]()
SIR 2027 records the most abstracts ever submitted!
![]()
SIR 2027 set a new record with 1,675 abstract submissions. Learn more and explore SIR Foundation award opportunities by Nov. 15.
SIR Annual Scientific Meeting
Continuous education
Featured
-
Guidewire
![]()
Member benefit spotlight: SIR standardized reports
![]()
News description needed
Quality improvement
Practice development
Membership
![]()
More news from SIR
![]()
-
Guidewire
Updated guidelines for adult cancer pain
NCCN has incorporated an SIR recommendation into its 2026 Adult Cancer Pain Guidelines. View the updated guideline.
-
Guidewire
VIRTEX measure supports consistent assessment of liver cancer treatment response
VIRTEX helps IR practices consistently assess liver cancer treatment response and use outcomes data to support quality improvement.
Quality improvement Practice development VIRTEX Clinical data registries -
Guidewire
New paper outlines growing role of IR in liver cancer treatment
Read more on how IRs are playing a growing, cost-efficient role in liver cancer care, according to new JVIR research.
IR research JVIR -
Guidewire
Is your practice visible to the patients and referring providers you want to reach?
Looking to grow your IR practice? Find healthcare marketing, branding and digital outreach experts in the SIR Vendor Directory to help expand awareness and strengthen referral networks.
-
Guidewire
SIR 2027 records the most abstracts ever submitted!
SIR 2027 set a new record with 1,675 abstract submissions. Learn more and explore SIR Foundation award opportunities by Nov. 15.
SIR Annual Scientific Meeting Continuous education Featured -
Guidewire
Member benefit spotlight: SIR standardized reports
News description needed
Quality improvement Practice development Membership
More news from SIR